BlackRock’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,751,705
| Closed | -$96.2M | – | 5370 |
|
|
2024
Q1 | $96.2M | Buy |
2,751,705
+36,033
| +1% | +$1.26M | ﹤0.01% | 2039 |
|
|
2023
Q4 | $103M | Buy |
2,715,672
+175,899
| +7% | +$6.68M | ﹤0.01% | 2027 |
|
|
2023
Q3 | $46.6M | Sell |
2,539,773
-6,830
| -0.3% | -$125K | ﹤0.01% | 2401 |
|
|
2023
Q2 | $66.1M | Buy |
2,546,603
+213,678
| +9% | +$5.55M | ﹤0.01% | 2278 |
|
|
2023
Q1 | $44M | Sell |
2,332,925
-83,263
| -3% | -$1.57M | ﹤0.01% | 2492 |
|
|
2022
Q4 | $59.5M | Buy |
2,416,188
+225,670
| +10% | +$5.56M | ﹤0.01% | 2320 |
|
|
2022
Q3 | $39.3M | Buy |
2,190,518
+213,407
| +11% | +$3.83M | ﹤0.01% | 2603 |
|
|
2022
Q2 | $22.4M | Buy |
1,977,111
+74,964
| +4% | +$851K | ﹤0.01% | 2967 |
|
|
2022
Q1 | $42.4M | Buy |
1,902,147
+7,680
| +0.4% | +$171K | ﹤0.01% | 2638 |
|
|
2021
Q4 | $82.7M | Buy |
1,894,467
+231,936
| +14% | +$10.1M | ﹤0.01% | 2314 |
|
|
2021
Q3 | $55.4M | Buy |
1,662,531
+165,358
| +11% | +$5.51M | ﹤0.01% | 2566 |
|
|
2021
Q2 | $41.2M | Buy |
1,497,173
+897,465
| +150% | +$24.7M | ﹤0.01% | 2789 |
|
|
2021
Q1 | $12M | Buy |
599,708
+104,676
| +21% | +$2.1M | ﹤0.01% | 3409 |
|
|
2020
Q4 | $16.3M | Buy |
495,032
+397,934
| +410% | +$13.1M | ﹤0.01% | 3049 |
|
|
2020
Q3 | $1.75M | Buy |
+97,098
| New | +$1.75M | ﹤0.01% | 3846 |
|